Synchron Integrates OpenAI-Powered Generative AI into Brain-Computer Interface Platform to Launch Advanced Chat Functionality

Brain-Computer Interface (BCI) company Synchron, which is dedicated to developing endovascular medical technologies aimed at restoring physical function in patients with motor impairments, recently announced that generative AI supported by OpenAI will be integrated into its BCI platform, launching a new chat feature.

Leveraging OpenAI’s advanced generative AI systems, Synchron has further enhanced the capabilities of its brain-computer interface (BCI) technology, enabling patients with severe paralysis who have lost upper limb mobility to interact with the digital world through thought alone.

Synchron’s BCI chat feature, powered by OpenAI, is designed to be simple, user-friendly, and easy to learn. It can now generate automated prompts for texting and chatting, categorized by context—including the user’s emotional state. This integration reflects the company’s patient-centric commitment to neurotechnology innovation, while Synchron does not share BCI users’ brain data with OpenAI.

Close-up view of the Synchron Stentrode device. Source: Synchron

“As someone who may lose the ability to communicate as my condition progresses, this technology gives me hope that I will still be able to easily connect with my loved ones in the future. This will be a game-changer,” said Mark, a patient with ALS who is using Synchron’s BCI platform.

“Because our users have lost the ability to make choices due to neurological conditions, generative AI can provide contextually relevant predictions, while BCI can facilitate personal choice,” said Tom Oxley, CEO and Founder of Synchron. “BCI upholds a fundamental human right: freedom of speech. We take our autonomy for granted until it is gone.”

OpenAI’s multimodal GPT generates content through text and audio, enabling more natural, real-time human-AI interaction. This is critical for individuals with neurological conditions who may otherwise struggle to produce complex responses based on their environment. Synchron will continue to evaluate the most advanced large language models (LLMs) best suited to the needs of Synchron BCI users.

Synchron BCI is implanted into the blood vessels on the surface of the brain's motor cortex via a minimally invasive endovascular procedure through the jugular vein. Once implanted, it is designed to detect and wirelessly transmit motor intentions from the brain, aiming to restore the ability of individuals with severe paralysis to control personal devices through hands-free clicking.

The updated BCI platform, powered by OpenAI’s advanced generative AI models, enables users to send text messages more efficiently. This includes faster response times, natural conversational pacing, and enhanced interaction via text messaging. These advancements will benefit a broad range of users, including those with upper-limb mobility impairments and other neurological conditions. Synchron’s mission is to develop best-in-class commercial BCIs that empower millions of people worldwide with upper-limb disabilities to interact with the world.

About Synchron

Synchron is a brain-computer interface (BCI) technology company dedicated to developing endovascular BCI solutions aimed at restoring physical function in patients with severe paralysis. This clinical-stage company is developing a neural prosthesis designed to restore motor signals, enabling patients with movement disorders to control digital devices and regain autonomy. Synchron is headquartered in New York City.